Library / regulatory-reference
Haiti: Ministry of Public Health and Population (MSPP)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Ministry of Public Health and Population, known by its French initials MSPP, is Haiti's national regulatory authority for medicines, acting through its pharmacy and medicines directorate.
Haiti's medicine supply depends heavily on imports and external assistance, and the ministry's registration and licensing decisions work alongside donor and international-organization procurement channels.
How products enter the market
Medicines require registration with supporting quality, safety and efficacy documentation, and establishments are licensed by the ministry.
Post-market oversight faces severe capacity constraints, and a large informal market for unregistered products is a persistent challenge.
Regional and international role
Haiti participates in Caribbean health cooperation, but its regulator relies more heavily than most on international partners for quality assurance and supply.
Its situation shows what regulation looks like where state capacity is limited and humanitarian supply chains carry much of the load.
Using this profile
The ministry publishes guidance and announcements in French and Creole through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Haiti illustrates the constrained-capacity regulator, where formal registration coexists with large informal and donor-supplied channels.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.